These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 25673705

  • 1. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ, Armstrong J, Lowen AC, Webster RG, Govorkova EA.
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [Abstract] [Full Text] [Related]

  • 2. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.
    Burnham AJ, Baranovich T, Marathe BM, Armstrong J, Webster RG, Govorkova EA.
    Antimicrob Agents Chemother; 2014 May; 58(5):2718-30. PubMed ID: 24566185
    [Abstract] [Full Text] [Related]

  • 3. Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
    Pascua PN, Marathe BM, Burnham AJ, Vogel P, Webby RJ, Webster RG, Govorkova EA.
    PLoS One; 2016 May; 11(7):e0159847. PubMed ID: 27466813
    [Abstract] [Full Text] [Related]

  • 4. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS, Jeong JH, Kwon JJ, Ahn SJ, Lloren KKS, Kwon HI, Chae HB, Hwang J, Kim MH, Kim CJ, Webby RJ, Govorkova EA, Choi YK, Baek YH, Song MS.
    J Virol; 2018 Jan 01; 92(1):. PubMed ID: 29046464
    [Abstract] [Full Text] [Related]

  • 5. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK.
    J Virol; 2015 Jan 01; 89(1):287-99. PubMed ID: 25320319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.
    Song MS, Marathe BM, Kumar G, Wong SS, Rubrum A, Zanin M, Choi YK, Webster RG, Govorkova EA, Webby RJ.
    J Virol; 2015 Nov 01; 89(21):10891-900. PubMed ID: 26292325
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
    Tang J, Zhang J, Zhou J, Zhu W, Yang L, Zou S, Wei H, Xin L, Huang W, Li X, Cheng Y, Wang D.
    Virol J; 2019 Jul 02; 16(1):87. PubMed ID: 31266524
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
    Govorkova EA, Ilyushina NA, Marathe BM, McClaren JL, Webster RG.
    J Virol; 2010 Aug 02; 84(16):8042-50. PubMed ID: 20519385
    [Abstract] [Full Text] [Related]

  • 17. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
    Sood R, Kumar N, Bhatia S, Chanu KV, Gupta CL, Pateriya AK, Mishra A, Khandia R, Mawale N, Singh VP.
    Antiviral Res; 2018 Oct 02; 158():143-146. PubMed ID: 30125616
    [Abstract] [Full Text] [Related]

  • 18. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D, Sleeman K, Huang W, Nguyen HT, Levine M, Cheng Y, Li X, Tan M, Xing X, Xu X, Klimov AI, Gubareva LV, Shu Y.
    Antiviral Res; 2013 Mar 02; 97(3):240-4. PubMed ID: 23267831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.